Compare BioNTech SE - ADR (BNTX) vs JetBlue Airways Corporation (JBLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs JetBlue Airways Corporation — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while JetBlue Airways Corporation trades at $5.81 (market cap $2.19B). The key difference: BioNTech SE - ADR is far larger — about 10.6× JetBlue Airways Corporation's market cap, and JetBlue Airways Corporation is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | JBLU | |
|---|---|---|
Market Cap | $23.31B | $2.19B |
Sector | Health | Industrials |
52-Week High | $119.34 | $6.46 |
52-Week Low | $83.89 | $4.03 |
Enterprise Value | $6.60B | $9.56B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.
Read more on JBLU →
